TRACON Pharmaceuticals Inc

NASDAQ:TCON   3:55:20 PM EDT
1.50
0.00 (+0.31%)
7:11:46 PM EDT: $1.51 +0.01 (+0.67%)
Earnings Announcements

TRACON Pharmaceuticals Reports Third Quarter 2022 Financial Results

Published: 11/14/2022 21:59 GMT
TRACON Pharmaceuticals Inc (TCON) - Tracon Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update.
Cash and Cash Equivalents Were $17.0 Million at September 30, 2022, Compared to $24.1 Million at December 31, 2021.
Cash and Cash Equivalents Expected to Fund Co Into Mid-2023.
Qtrly Loss per Share $0.30.
Q3 Earnings per Share View $-0.28 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.29

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.25

More details on our Analysts Page.